Observed side effects in research settings are generally mild and may include temporary nausea-related observations, flushing-related observations, headache-related observations, fatigue-related observations, administration-site irritation, pigmentation variability, pigmentation variability involving freckles or moles, and temporary appetite-related response variability depending on research amount, UV exposure, administration frequency, skin type, and individual physiological sensitivity
CLINICAL Review: The role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: Clinical implications
Understanding these differences helps clinicians and patients make informed treatment decisions
Its effects on inflammatory markers appear similar to other agents in the class, though with potentially less weight loss benefit than newer agents like semaglutide